| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $7.02B | $6.07B | $3.95B |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | $1.75B | $1.88B | $0 |
| Gross Margin % | 25.0% | 31.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.50B | $1.61B | $1.41B |
| Operating Margin % | 21.3% | 26.6% | — |
| Net Income (GAAP) | $1.30B | $1.21B | $1.23B |
| EBITDA (Normalized) | $2.09B | $2.18B | $1.41B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.71B | $1.57B | $1.88B |
| Capital Expenditures (CapEx) | $745.6M | $713.5M | $0 |
| Free Cash Flow (FCF) | $965.8M | $852.3M | $1.88B |
| FCF Margin % | 13.8% | 14.0% | — |
| Return on Invested Capital (ROIC %) | 12.3% | 15.0% | 21.9% |
| Cash & Short-Term Equivalents | $1.43B | $1.84B | — |
| Total Debt (Short + Long Term) | $1.54B | $1.83B | $1.97B |
| Total Stockholders' Equity | $9.49B | $8.50B | $4.04B |